Eosinophil Activation Status in Separate Compartments and Association with Asthma

Area of Science:

• Immunology
• Respiratory Medicine
• Cell Biology

Background:

• Asthma is characterized by eosinophil-driven airway inflammation, exacerbations, and remodeling.
• Eosinophil recruitment involves activation, adhesion to endothelium, extravasation, and migration via extracellular matrix (ECM) interactions.
• Circulating eosinophils vary in activation states (non-activated vs. pre-activated).

Purpose of the Study:

• To review eosinophil surface proteins as biomarkers of activation in asthma.
• To explore correlations between eosinophil activation states and asthma manifestations.
• To investigate how eosinophil surface proteins respond to different therapeutic interventions.

Main Methods:

• Review of literature on eosinophil surface protein expression and activation states in asthma.
• Analysis of correlations between specific surface proteins (e.g., integrins) and clinical parameters.
• Comparison of eosinophil phenotypes in blood, bronchoalveolar lavage (BAL), and lung tissue.

Main Results:

• Increased/decreased expression of surface proteins like CD44, CD45, and integrins correlates with asthma.
• Intermediate activation of beta1 and beta2 integrins on blood eosinophils is linked to reduced pulmonary function in non-severe asthma.
• Bronchoalveolar lavage (BAL) eosinophils exhibit higher integrin activation and altered surface proteins compared to blood eosinophils.

Conclusions:

• Eosinophil surface protein activation states, particularly integrins, serve as potential biomarkers for asthma.
• The correlation between blood eosinophil activation and asthma severity differs between non-severe and severe disease.
• Tissue eosinophil phenotypes remain largely uncharacterized but may differ significantly from those in BAL or sputum.